PHA SCR nsp14
Aus coViki
(Unterschied zwischen Versionen)
Ossip Groth (Diskussion | Beiträge)
(Die Seite wurde neu angelegt: „{{up|PHA pharmacophore by screened target}} {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(nsp14+OR+non-structural+prot…“)
(Die Seite wurde neu angelegt: „{{up|PHA pharmacophore by screened target}} {{plb|((covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov))+AND+(nsp14+OR+non-structural+prot…“)
Aktuelle Version vom 21. April 2021, 20:28 Uhr
| PHA pharmacophore by screened target |
| living current stringent pubmed readout on nsp14 |
32875166 2020. In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors.
32907334 2020. Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.
32923004 2020. Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2.
